|
1
|
Painter JA, Graviss EA, Hai HH, Nhung DT,
Nga TT, Ha NP, Wall K, le Loan TH, Parker M, Manangan L, et al:
Tuberculosis screening by tuberculosis skin test or QuantiFERON-TB
Gold in-tube assay among an immigrant population with a high
prevalence of tuberculosis and BCG vaccination. Plos One.
8:e827272013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
James PM, Ganaie FA and Kadahalli RL: The
performance of quantiferon-TB gold in-tube (QFT-IT) test compared
to tuberculin skin test (TST) in detecting latent tuberculosis
infection (LTBI) in the presence of HIV coinfection in a high
TB-burden area with BCG-vaccinated population. J Int Assoc Provid
AIDS Care. 13:47–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Favorov M, Ali M, Tursunbayeva A,
Aitmagambetova I, Kilgore P, Ismailov S and Chorba T: Comparative
tuberculosis (TB) prevention effectiveness in children of Bacillus
Calmette-Guerin (BCG) vaccines from different sources, Kazakhstan.
Plos One. 7:e325672012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nkurunungi G, Lutangira JE, Lule SA,
Akurut H, Kizindo R, Fitchett JR, Kizito D, Sebina I, Muhangi L,
Webb EL, et al: Determining mycobacterium tuberculosis infection
among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin
skin testing. Plos One. 7:e473402012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Urzua CA, Liberman P, Abuauad S, Sabat P,
Castiglione E, Beltran-Videla MA and Aguilera R: Evaluation of the
accuracy of T-SPOT.TB for the diagnosis of ocular tuberculosis in a
BCG-vaccinated, non-endemic population. Ocul Immunol Inflamm.
25:455–459. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Minassian AM, Ronan EO, Poyntz H, Hill AV
and McShane H: Preclinical development of an in vivo BCG challenge
model for testing candidate TB vaccine efficacy. Plos One.
6:e198402011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bishai W, Sullivan Z, Bloom BR and
Andersen P: Bettering BCG: A tough task for a TB vaccine? Nat Med.
19:410–411. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saubi N, Gea-Mallorquí E, Ferrer P,
Hurtado C, Sánchez-Úbeda S, Eto Y, Gatell JM, Hanke T and Joseph J:
Engineering new mycobacterial vaccine design for HIV-TB pediatric
vaccine vectored by lysine auxotroph of BCG. Mol Ther Methods Clin
Dev. 1:140172014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang G, Zhang L, Zhang M, Pan L, Wang F,
Huang J, Li G, Yu J and Hu S: Screening and assessing 11
mycobacterium tuberculosis proteins as potential serodiagnostical
markers for discriminating TB patients from BCG vaccinees. Genomics
Proteomics Bioinformatics. 7:107–115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rapeah S, Dhaniah M, Nurul AA and Norazmi
MN: Phagocytic activity and pro-inflammatory cytokines production
by the murine macrophage cell line J774A.1 stimulated by a
recombinant BCG (rBCG) expressing the MSP1-C of Plasmodium
falciparum. Trop Biomed. 27:461–469. 2010.PubMed/NCBI
|
|
11
|
Wammes LJ, Hamid F, Wiria AE, de Gier B,
Sartono E, Maizels RM, Luty AJ, Fillié Y, Brice GT, Supali T, et
al: Regulatory T cells in human geohelminth infection suppress
immune responses to BCG and Plasmodium falciparum. Eur J Immunol.
40:437–442. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng C, Xie P and Chen Y: Recombinant
mycobacterium bovis BCG producing the circumsporozoite protein of
Plasmodium falciparum FCC-1/HN strain induces strong immune
responses in BALB/c mice. Parasitol Int. 51:1–7. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mohamad D, Suppian R and Nor Mohd N:
Immunomodulatory effects of recombinant BCG expressing MSP-1C of
Plasmodium falciparum on LPS- or LPS+IFN-gamma-stimulated J774A.1
cells. Hum Vaccin Immunother. 10:1880–1886. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Teo WH, Nurul AA and Norazmi MN:
Immunogenicity of recombinant BCG-based vaccine expressing the 22
kDa of serine repeat antigen (SE22) of Plasmodium falciparum. Trop
Biomed. 29:239–253. 2012.PubMed/NCBI
|
|
15
|
Nurul AA, Rapeah S and Norazmi MN:
Plasmodium falciparum 19 kDa of merozoite surface protein-1
(MSP-1(19)) expressed in Mycobacterium bovis bacille Calmette
Guerin (BCG) is reactive with an inhibitory but not a blocking
monoclonal antibody. Trop Biomed. 27:60–67. 2010.PubMed/NCBI
|
|
16
|
Zibara K, Awada Z, Dib L, El-Saghir J,
Al-Ghadban S, Ibrik A, El-Zein N and El-Sabban M: Anti-angiogenesis
therapy and gap junction inhibition reduce MDA-MB-231 breast cancer
cell invasion and metastasis in vitro and in vivo. Sci Rep.
5:125982015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Frevert U, Nacer A, Cabrera M, Movila A
and Leberl M: Imaging Plasmodium immunobiology in the liver, brain,
and lung. Parasitol Int. 63:171–186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Villarreal DO, Walters J, Laddy DJ, Yan J
and Weiner DB: Multivalent TB vaccines targeting the esx gene
family generate potent and broad cell-mediated immune responses
superior to BCG. Hum Vaccin Immunother. 10:2188–2198. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garza-Cuartero L, McCarthy E, Brady J,
Cassidy J, Hamilton C, Sekiya M, NcNair J and Mulcahy G:
Development of an in vitro model of the early-stage bovine
tuberculous granuloma using mycobacterium bovis-BCG. Vet Immunol
Immunopathol. 168:249–257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jallad S, Goubet S, Symes A, Larner T and
Thomas P: Prognostic value of inflammation or granuloma after
intravesival BCG in non-muscle-invasive bladder cancer. BJU Int.
113:E22–E27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arkhipov SA, Shkurupy VA, Akhramenko ES,
Solomatina MV and Iljine DA: In vitro study of phenotypical
characteristics of BCG granuloma macrophages over the course of
granuloma development. Bull Exp Biol Med. 155:655–658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nagase K, Koba S, Okawa T, Inoue T, Misago
N and Narisawa Y: Generalized granuloma annulare following BCG
vaccination, mimicking papular tuberculid. Eur J Dermatol.
21:1001–1002. 2011.PubMed/NCBI
|
|
23
|
Williams SB, Viani KL and Loughlin KR: A
72-year-old male with left testicular pain. Diagnosis: BCG
granuloma of the epididymis. Urology. 78:505–507. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fernando A and Montgomery B: Penile
granuloma following intravesical bacillus calmette-guerin (BCG)
therapy. Ann R Coll Surg Engl. 2010.PubMed/NCBI
|
|
25
|
Fairhurst RM and Dondorp AM:
Artemisinin-resistant Plasmodium falciparum Malaria. Microbiol
Spectr. 4:2016.PubMed/NCBI
|
|
26
|
Stevenson JC, Simubali L, Mbambara S,
Musonda M, Mweetwa S, Mudenda T, Pringle JC, Jones CM and Norris
DE: Detection of Plasmodium falciparum Infection in Anopheles
squamosus (Diptera: Culicidae) in an Area Targeted for Malaria
Elimination, Southern Zambia. J Med Entomol. 53:1482–1487. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Palinauskas V, Žiegytė R, Iezhova TA,
Ilgūnas M, Bernotienė R and Valkiūnas G: Description, molecular
characterisation, diagnostics and life cycle of Plasmodium
elongatum (lineage pERIRUB01), the virulent avian malaria parasite.
Int J Parasitol. 46:697–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Annabi A, Said K and Messaoudi I:
Monitoring and assessment of environmental disturbance on natural
Gambusia affinis populations-histopathological analysis. Environ
Monit Assess. 187:3182015. View Article : Google Scholar : PubMed/NCBI
|
